Form 4 · Filed May 4, 2026, 08:58 PM UTC
JNJ/JOHNSON & JOHNSON
REED JOHN C — EVP, Innovative Medicine, R&D
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | M | other | 25,255 | $0 | — | 35,913 |
| May 1, 2026 | F | other | 11,002 | $230 | $2,528,810 | 24,911 |
| May 1, 2026 | M | other | 25,255 | $0 | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0000200406-26-000115